Tuesday, February 23, 2010

23 Feb - In the News

High profile stories about aspirin and rosiglitazone sure to stimulate conversations with your patients.  Be sure to calculate a Framingham risk score to help counsel patients about the risk / benefit of daily aspirin.   Based on the above story, those with higher Framingham risk scores may not be good candidates for rosiglitazone until the heart disease risk issue is resolved.

No comments:

Post a Comment